Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
Cystic leukoencephalopathy without megalencephaly is a disorder related in some cases to RNASET2 mutations and characterized by bilateral anterior temporal subcortical cysts and multifocal lobar white matter lesions with sparing of central white matter structures.
|
27091087 |
2016 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.
|
25655951 |
2015 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A practical approach to diagnosing adult onset leukodystrophies.
|
24357685 |
2014 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
rnaset2 mutant zebrafish model familial cystic leukoencephalopathy and reveal a role for RNase T2 in degrading ribosomal RNA.
|
21199949 |
2011 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection.
|
19525954 |
2009 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection.
|
19525954 |
2009 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection.
|
19525954 |
2009 |
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
Leukoencephalopathy, Cystic, Without Megalencephaly
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Graves Disease
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
This study was designed to unveil the association of GPR174 rs3827440, PTPN22 rs3789604, and RNASET2 rs9355610 with the onset of liver damage (LD) among the Graves' disease (GD) patients.
|
28568286 |
2018 |
Graves Disease
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that the rs9355610 tag SNP of RNASET2 gene is positively associated with susceptibility to GD in the Chinese Han population.
|
25928629 |
2015 |
Graves Disease
|
0.320 |
Biomarker
|
disease |
CTD_human |
A genome-wide association study identifies two new risk loci for Graves' disease.
|
21841780 |
2011 |
Lung Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.
|
28604730 |
2017 |
Malignant neoplasm of lung
|
0.300 |
Biomarker
|
disease |
CTD_human |
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.
|
28604730 |
2017 |
Intellectual Disability
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Brain Diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
Congenital cytomegalovirus infection and RNASET2 deficiency may both interfere with brain development and myelination through angiogenesis or RNA metabolism.
|
19525954 |
2009 |
Encephalopathies
|
0.300 |
Biomarker
|
group |
CTD_human |
RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection.
|
19525954 |
2009 |
Vitiligo
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.
|
27723757 |
2016 |
Vitiligo
|
0.110 |
Biomarker
|
disease |
BEFREE |
Thus, RNASET2 may contribute to vitiligo pathogenesis by inhibiting TRAF2 expression and, as such, RNASET2 may represent a potential therapeutic target of vitiligo.
|
24457966 |
2014 |
Vitiligo
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
|
20526339 |
2010 |
Vitiligo
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
|
20526339 |
2010 |
Fetal Membranes, Premature Rupture
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A genome-wide association study of early spontaneous preterm delivery.
|
25599974 |
2015 |
Lymphocyte Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
The combination of a genome-wide association study of lymphocyte count and analysis of gene expression data reveals novel asthma candidate genes.
|
22286170 |
2012 |
Poor speech
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|